Welcome to HSCO!
The Voice of Oncology in Hawaii
The Hawaii Society of Clinical Oncology strives to be the voice of Hawaii's oncologists and oncology professionals and to promote quality oncology care through patient advocacy, continuing education, multidisciplinary engagement, and participation in the public forum.
What's New @ HSCO:
HSCO Submits Letter Regarding Medicare Part B to Department of Health and Human Services
ALUNBRIG (brigatinib) Receives FDA Approval
New XTANDI TERRAIN & PREVAIL Trial Data Available
AstraZeneca's TAGRISSO® (osimertinib) Receives FDA Full Approval
View the HSCO 2016 Year in Review!